Pharmaboom Articles

A troubling study in the September 3rd Journal of the American Medical Association raises new concerns about kids committing suicide in this country. After a one year spike in the number of suicides, doctors were hoping to see more normal numbers in the latest study, but they didn’t. The number of kids committing suicide in the U.S. remains higher than expected, and that Read the rest of this entry »

GlaxoSmithKline (GSK) announced that the European Commission has issued marketing authorisation for Volibris® (ambrisentan) for the treatment of Pulmonary Arterial Hypertension (PAH) in patients classified as World Health Organisation (WHO) Functional Class II and III, to improve exercise capacity.1 Efficacy has been shown in idiopathic PAH (IPAH) and in PAH associated Read the rest of this entry »

UroToday.com - In this very important and unique study, the authors note that at 19.2 years average follow-up after percutaneous stone removal (PCNL), the incidence of hypertension (34.1%) is no different than after shock wave lithotripsy (SWL) (36.4%).
Of note, the incidence of diabetes (23.5%) at Read the rest of this entry »

The Medicines Company (NASDAQ: MDCO) today announced that data from two post-hoc analyses of the ECLIPSE trial showed that use of Cleviprex™ (clevidipine butyrate) injectable emulsion to control blood pressure during cardiac surgery may be associated with a reduced risk of heart attack compared to two of three currently used IV antihypertensive agents. Read the rest of this entry »

Expectant mothers can safely use prescribed antidepressants during their first trimester, according to a new study from the Universit?© de Montr?©al and Ste. Justine Hospital published in the May edition of the British Journal of Psychiatry.
Dr. generic soma online buy Anick B?©rard and her team found Read the rest of this entry »

It has previously been claimed that working as a baker involves, as a
consequence, a great risk of evolving allergy and respiratory symptoms.
The basis for this assumption was based on cross-sectional studies.
In this study, undertaken by Tina Skjodt (Aarhus University Hospital,
Aarhus, Denmark) and her team, bakers’ apprentices were followed
Read the rest of this entry »

Working hard when fatigued may be admired by many Americans, but it is a virtue that could be harmful to one’s health, according to new research by psychologists at the University of Alabama at Birmingham (UAB). The research supports a theory which suggests that exhausted individuals’ cardiovascular systems are forced to work harder when they attempt to complete tasks, such as those encountered on the job or at school.
The research, published Read the rest of this entry »

The Medical Defence Union, the UK’s largest medical defence organisation, has revealed it paid out nearly ??3m in compensation on behalf of GP members to settle 30 claims arising from the treatment of patients with depression during a recent ten-year-period.
Generic zithromax Read the rest of this entry »

An innovative study appearing in the August issue of The Journal of Sexual Medicine examined, for the first time, if noseless bicycle saddles would be an effective intervention for alleviating deleterious health effects, erectile dysfunction and groin numbness, caused by bicycling on the traditional saddle with a protruding nose extension. Read the rest of this entry »

A new treatment programme for cancer patients with clinical depression can significantly boost their quality of life according to new research published in the Lancet.
Cancer Research UK scientists devised the treatment programme which offers patients one-to-one sessions with specially trained cancer nurses to help them Read the rest of this entry »

BioMedEcon, a leading provider of health economics and outcomes research, presented findings from a landmark nine-year retrospective claims analysis that compared the median per-patient health care costs for patients with obsessive-compulsive disorder (OCD) versus depression. This study, supported by Jazz Pharmaceuticals, Inc., was presented at the International Society for Pharmacoeconomics and Outcomes Research Read the rest of this entry »

People suffering from anxiety and depression prefer to receive counselling over medication because they feel it addresses their underlying problems and not just their symptoms.
This is one of the key findings in a review of UK and international research studies into the clinical-effectiveness, cost-effectiveness and acceptability of counselling. The review, Counselling Read the rest of this entry »

Mom and Dad are going to flip out over my 3.3 GPA and failure to land a top internship.
Such anxieties, common among college students, can harm self-esteem and make it more difficult to adjust to school. But a new University of Central Florida study has found that students’ anxieties often are based on exaggerated perceptions of what their parents expect.
The problem, UCF psychologist Kimberly Renk says, is that many parents and students hold different perceptions Read the rest of this entry »

A paper by Giovanni A. Fava and associates of the University of Bologna published in the April issue of Psychotherapy and Psychosomatics summarizes the evidence which supports the seriousness of agoraphobia as an invalidating disease. At the same time it questions the excessive emphasis on panic which has been attributed in the past decade and the role of pharmaceutical industry in this attribution.
Read the rest of this entry »

A new Harris Interactive phone survey conducted among 1,000 allergy sufferers, 1,000 consumers (both allergy sufferers and non-sufferers) and 300 physicians shows that beyond the sneezing, sniffling and watery eyes, allergies also have deep and emotional impacts on a sufferer’s mood and self-perceptions.
According to "Attitudes About Allergies," Read the rest of this entry »

Americans spent $11 billion on doctors’ bills, prescription drugs, and other medical care to relieve allergy symptoms such as itchy or watery eyes, stuffy noses, wheezing, coughing, and headaches in 2005, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. The cost is nearly double the $6 billion spent in 2000.
AHRQ’s analysis Read the rest of this entry »

Their gentle nature, large size, odd sounds and low-maintenance care have made Madagascar hissing cockroaches popular educational tools and pets for years. But the giant insects also have one unfortunate characteristic: Their hard bodies and feces are home to many mold species that could be triggering allergies in the kids and adults who handle the bugs, according to a new study.
Researchers have identified Read the rest of this entry »

The House of Lords will on Thursday 8 May debate the Science and Technology Committee’s report on Allergy which was published in September last year.
The Government responded to the report in November and accepted many of the Committee’s recommendations. The Read the rest of this entry »

Leadership from the American Academy of Allergy Asthma & Immunology and the American College of Allergy, Asthma & Immunology released the following statement in response to the Thursday announcement of a Food and Drug Administration Read the rest of this entry »

AstraZeneca announced that the company has submitted applications in the European Union (EU) for once-daily SEROQUEL XR™ (quetiapine fumarate) Extended-Release Tablets (quetiapine XR), seeking approval for the treatment of major depressive disorder (MDD) including maintenance therapy in adult patients using Mutual Recognition Procedure (MRP). This follows an sNDA submission for SEROQUEL XR in MDD in Read the rest of this entry »

Erectile dysfunction is always a matter of the heart, but new research shows that more than romance is at stake. Two new studies of men with type 2 diabetes found that erectile dysfunction (ED) was a powerful early warning sign for serious heart disease, including heart attack and death.
One of the studies also showed that cholesterol-lowering Read the rest of this entry »

The U.S. Food and Drug Administration requested that SEI Pharmaceuticals, of Miami, Fla., recall all Xiadafil VIP Tabs sold in 8 tablet bottles (Lot # 6K029) or blister cards of 2 tablets (Lot # 6K029-SEI) because these products contain a potentially harmful, undeclared ingredient that may dangerously affect a person’s blood pressure and can cause other life-threatening side effects. These lots of Xiadafil Read the rest of this entry »

"The blood froze in my veins" or "My blood curdled" - these common figures of speech can be taken literally, according to the latest studies. Indeed, more literally than some of us would like. For it turns out that intense fear and panic attacks can really make our blood clot and increase the risk of thrombosis or heart attack.
Earlier studies showed that stress and anxiety can influence coagulation. Read the rest of this entry »

Adding the relaxation response, a stress-management approach, to other lifestyle interventions may significantly improve treatment of the type of hypertension most common in the elderly. Among participants in a study conducted at the Massachusetts General Hospital (MGH) Hypertension Program and the Benson-Henry Institute for Mind-Body Medicine at MGH, those who received relaxation response Read the rest of this entry »

NexMed, Inc. (Nasdaq: NEXM), a developer of innovative transdermal products based on its proprietary NexACT® drug delivery technology, announced that the New Drug Application (NDA) filed by the Company for its erectile dysfunction (ED) product, a topically applied alprostadil cream, was Read the rest of this entry »